These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15269637)

  • 1. Serum homocysteine concentrations in children with inflammatory bowel disease.
    Eren M; Nur Saltik-Temizel I; Koçak N
    J Pediatr Gastroenterol Nutr; 2004 Aug; 39(2):215-6. PubMed ID: 15269637
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications.
    Erzin Y; Uzun H; Celik AF; Aydin S; Dirican A; Uzunismail H
    J Clin Gastroenterol; 2008; 42(5):481-6. PubMed ID: 18344891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of hyperchomocysteinemia in patients with inflammatory bowel disease: a pathogenic link with thromboembolic complications?
    Cattaneo M; Vecchi M; Zighetti ML; Saibeni S; Martinelli I; Omodei P; Mannucci PM; de Franchis R
    Thromb Haemost; 1998 Oct; 80(4):542-5. PubMed ID: 9798965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homocysteine in patients with inflammatory bowel diseases.
    Owczarek D; Cibor D; Sałapa K; Jurczyszyn A; Mach T
    Przegl Lek; 2014; 71(4):189-92. PubMed ID: 25141576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral challenge with a methionine load in patients with inflammatory bowel disease: a better test to identify hyperhomocysteinemia.
    Zepeda-Gómez S; Montano-Loza A; Zapata-Colindres JC; Vargas-Vorackova F; Majluf-Cruz A; Uscanga L
    Inflamm Bowel Dis; 2008 Mar; 14(3):383-8. PubMed ID: 17924554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperhomocysteinemia and methylenetetrahydrofolate reductase 677C-->T and 1298A-->C mutations in patients with inflammatory bowel disease.
    Fernández-Miranda C; Martínez Prieto M; Casis Herce B; Sánchez Gómez F; Gómez González P; Martínez López J; Sáenz-López Pérez S; Gómez de la Cámara A
    Rev Esp Enferm Dig; 2005 Jul; 97(7):497-504. PubMed ID: 16262529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma homocysteine and arterial thromboembolic disease.
    Mbewu AD; Nogoduka C; Taylor B
    S Afr Med J; 2003 Mar; 93(3):192-4. PubMed ID: 12768941
    [No Abstract]   [Full Text] [Related]  

  • 8. Hyperhomocystinemia in children with inflammatory bowel disease.
    Nakano E; Taylor CJ; Chada L; McGaw J; Powers HJ
    J Pediatr Gastroenterol Nutr; 2003 Nov; 37(5):586-90. PubMed ID: 14581802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseases.
    Oussalah A; Guéant JL; Peyrin-Biroulet L
    Aliment Pharmacol Ther; 2011 Nov; 34(10):1173-84. PubMed ID: 21967576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular and cellular stress in inflammatory bowel disease: revisiting the role of homocysteine.
    Peyrin-Biroulet L; Rodriguez-Guéant RM; Chamaillard M; Desreumaux P; Xia B; Bronowicki JP; Bigard MA; Guéant JL
    Am J Gastroenterol; 2007 May; 102(5):1108-15. PubMed ID: 17355415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombophilic factors in Turkish children with inflammatory bowel disease.
    Eren M; Saltik-Temizel IN; Demir H; Koçak N; Ozen H; Gürakan F; Yüce A
    Indian J Gastroenterol; 2006; 25(6):318-9. PubMed ID: 17264441
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hyperhomocysteinemia: a risk factor for arterial and venous thrombosis].
    Wuillemin WA; Solenthaler M
    Vasa; 1999 Aug; 28(3):151-5. PubMed ID: 10483317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homocysteine in inflammatory bowel disease: a risk factor for thromboembolic complications?
    Oldenburg B; Fijnheer R; van der Griend R; vanBerge-Henegouwen GP; Koningsberger JC
    Am J Gastroenterol; 2000 Oct; 95(10):2825-30. PubMed ID: 11051355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperhomocysteinemia is common in patients with antiphospholipid syndrome and may contribute to expression of major thrombotic events.
    Avivi I; Lanir N; Hoffman R; Brenner B
    Blood Coagul Fibrinolysis; 2002 Mar; 13(2):169-72. PubMed ID: 11914660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are B vitamins a risk factor for VTE? Perhaps.
    den Heijer M
    J Thromb Haemost; 2006 Feb; 4(2):309-11. PubMed ID: 16420556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are B vitamins a risk factor for venous thromboembolism? Yes.
    Eichinger S
    J Thromb Haemost; 2006 Feb; 4(2):307-8. PubMed ID: 16420555
    [No Abstract]   [Full Text] [Related]  

  • 17. Hyperhomocysteinemia and inflammatory bowel disease: prevalence and predictors in a cross-sectional study.
    Romagnuolo J; Fedorak RN; Dias VC; Bamforth F; Teltscher M
    Am J Gastroenterol; 2001 Jul; 96(7):2143-9. PubMed ID: 11467646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperhomocysteinemia and related factors in 600 hospitalized elderly subjects.
    Ventura P; Panini R; Verlato C; Scarpetta G; Salvioli G
    Metabolism; 2001 Dec; 50(12):1466-71. PubMed ID: 11735095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperhomocysteinemia and B-vitamin status after discontinuation of oral anticoagulation therapy in patients with a history of venous thromboembolism.
    Sobczyńska-Malefora A; Harrington DJ; Rangarajan S; Kovacs JA; Shearer MJ; Savidge GF
    Clin Chem Lab Med; 2003 Nov; 41(11):1493-7. PubMed ID: 14656031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperhomocysteinemia as a potential contributor of colorectal cancer development in inflammatory bowel diseases: a review.
    Keshteli AH; Baracos VE; Madsen KL
    World J Gastroenterol; 2015 Jan; 21(4):1081-90. PubMed ID: 25632180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.